MRF Limited (NSE:MRF)

Verve Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	3,706	3,031	2,485	2,544	1,669
Short-Term Investments	1,440	1,815	-	6,000	-
Trading Asset Securities	34,134	22,620	19,748	25,214	47,443
Cash & Short-Term Investments	39,281	27,466	22,234	33,758	49,111
Cash Growth	43.02%	23.53%	-34.14%	-31.26%	82.42%
Accounts Receivable	33,703	29,120	25,033	23,327	21,460
Other Receivables	484.6	429.2	395	525.4	555.1
Receivables	34,237	29,607	25,457	23,884	22,082
Inventory	56,248	44,686	41,411	41,297	29,388
Prepaid Expenses	632.8	533.1	460.2	425	336.6
Other Current Assets	3,566	3,204	2,850	3,273	2,710
Total Current Assets	133,964	105,496	92,412	102,637	103,628
Property, Plant & Equipment	143,681	144,050	131,379	107,337	104,187
Long-Term Investments	11,375	11,237	11,130	11,377	12,052
Other Intangible Assets	213.3	257.4	259.4	212.3	243.3
Other Long-Term Assets	6,360	7,412	8,501	9,025	5,682
Total Assets	295,670	268,494	243,694	230,597	225,819
Accounts Payable	28,220	26,528	24,358	20,568	33,061
Accrued Expenses	7,235	7,424	6,989	6,438	6,032
Short-Term Debt	21,759	12,458	14,433	16,978	9,154
Current Portion of Long-Term Debt	3,546	1,052	1,627	3,030	2,935
Current Portion of Leases	1,110	911.9	754.9	600.8	549.9
Current Income Taxes Payable	63	43.1	36.7	38.2	37.6
Current Unearned Revenue	599.5	659.2	569.3	684	450.2
Other Current Liabilities	27,064	28,024	26,187	21,231	20,457
Total Current Liabilities	89,596	77,100	74,953	69,567	72,677
Long-Term Debt	3,744	7,241	8,236	8,172	8,118
Long-Term Leases	7,553	6,552	5,086	3,509	3,126
Long-Term Unearned Revenue	2,171	2,450	2,206	1,643	1,712
Long-Term Deferred Tax Liabilities	4,624	4,620	3,846	3,955	3,802
Other Long-Term Liabilities	2,444	2,890	1,750	2,919	1,726
Total Liabilities	110,784	101,463	96,616	90,278	91,681
Common Stock	42.4	42.4	42.4	42.4	42.4
Additional Paid-In Capital	94.2	94.2	94.2	94.2	94.2
Retained Earnings	185,693	167,849	147,779	140,725	134,669
Comprehensive Income & Other	-945.1	-955.2	-838.5	-544.4	-668.8
Total Common Equity	184,885	167,030	147,077	140,318	134,137
Minority Interest	1.8	1.7	1.6	1.5	1.4
Shareholders' Equity	184,886	167,032	147,078	140,319	134,138
Total Liabilities & Equity	295,670	268,494	243,694	230,597	225,819
Total Debt	37,712	28,215	30,136	32,290	23,882
Net Cash (Debt)	1,569	-749.3	-7,903	1,469	25,229
Net Cash Growth	-	-	-	-94.18%	453.36%
Net Cash Per Share	369.95	-176.67	-1863.32	346.32	5948.56
Filing Date Shares Outstanding	4.24	4.24	4.24	4.24	4.24
Total Common Shares Outstanding	4.24	4.24	4.24	4.24	4.24
Working Capital	44,368	28,395	17,459	33,069	30,952
Book Value Per Share	43593.11	39383.23	34678.53	33084.83	31627.49
Tangible Book Value	184,671	166,773	146,817	140,105	133,893
Tangible Book Value Per Share	43542.81	39322.54	34617.37	33034.77	31570.12
Land	6,120	6,062	5,831	5,804	5,795
Buildings	46,044	41,853	35,825	31,971	30,540
Machinery	156,947	136,573	113,380	103,220	93,933
Construction In Progress	11,686	23,845	30,459	12,331	10,022

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.